124 participants
An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-04
- Start Date:
- 2015-03-02
- Completion:
- 2020-12-04
Conditions
- Mantle Cell Lymphoma (MCL)
Interventions
- DRUG